Skip to main content

Table 1 Baseline sociodemographic, reproductive health, and clinical characteristics according to CHW and CIC groups

From: Recruitment strategies to promote uptake of cervical cancer screening in the West Region of Cameroon

 

CIC, n (%)

CHW, n (%)

Total, n (%)

P-value*

Variable

Participants recruited

1356 (69.9%)

584 (30.1%)

1940 (100%)

 

Age (years), mean ± SD

39.4 (±5.9)

41.9 (±5.6)

40.2 (±5.9)

<  0.001

Marital status

   

<  0.001

 Single

121 (8.9%)

25 (4.3%)

146 (7.5%)

 

 Married/In a relationship

1155 (85.2%)

494 (84.6%)

1649 (85%)

 

 Divorced/widowed

78 (5.8%)

64 (11.0%)

142 (7.3%)

 

Education

   

<  0.001

 Unschooled

5 (0.4%)

9 (1.5%)

14 (0.7%)

 

 Primary education

275 (20.3%)

274 (46.9%)

549 (28.3%)

 

 Secondary education

759 (56.0%)

274 (46.9%)

1033 (53.3%)

 

 Tertiary education

315 (23.2%)

24 (4.1%)

339 (17.5%)

 

Employment status

   

<  0.001

 Employed

480 (35.4%)

62 (10.6%)

542 (27.9%)

 

 Self-employed

412 (30.4%)

121 (20.7%)

533 (27.5%)

 

 Farmer

130 (10.0%)

249 (42.6%)

379 (19.5%)

 

 Housewife

274 (20.2%)

147 (25.2%)

421 (21.7%)

 

 Student

50 (3.7%)

4 (0.7%)

54 (2.8%)

 

 Unemployed

8 (0.6%)

0

8 (0.4%)

 

Age at menarche (years), mean ± SD

14.6 (1.8)

14.9 (1.7)

14.7 (1.8)

<  0.001

Age at first intercourse, mean ± SD

18.0 (2.9)

17.48 (2.4)

17.9 (2.8)

<  0.001

Number of sexual partners, median (IQR)

3 (2–5)

3 (2–4)

3 (2–5)

 

Age at first delivery (years), mean ± SD

21.3 (5.8)

19.8 (4.3)

20.9 (5.4)

<  0.001

Parity

   

<  0.001

 Nulliparous

65 (4.8%)

13 (2.2%)

78 (4.0%)

 

 1–4

662 (48.8%)

166 (28.4%)

828 (42.9%)

 

  > 4

627 (46.2%)

404 (69.2%)

1031 (53.1%)

 

Tabaco consumption

   

<  0.001

 Yes

7 (0.5%)

27 (4.6%)

34 (1.8%)

 

 None

1347 (99.3%)

555 (95.0%)

1902 (98.0%)

 

Contraception

   

<  0.001

 None

924 (68.1%)

430 (73.6%)

1354 (69.8%)

 

 Condom

189 (13.9%)

21 (3.6%)

210 (10.8%)

 

 Hormonal pill

23 (1.7%)

8 (1.4%)

31 (1.6%)

 

 DIU/ implant/ injection

199 (14.7%)

117 (20.0%)

316 (16.3%)

 

 Other

16 (1.2%)

5 (0.9%)

21 (1.1%)

 

Previous cervical cancer screening

   

<  0.001

 None

1025 (75.6%)

560 (95.9%)

1585 (81.7%)

 

 Yes

329 (24.3%)

23 (3.9%)

352 (18.1%)

 

HIV status (self-reported)

   

0.791

 Negative

1327 (97.9%)

574 (98.3%)

1901 (98.0%)

 

 Positive

27 (2.0%)

9 (1.5%)

36 (1.9%)

 

HPV testing results

   

0.287

 Negative

1096 (80.8%)

484 (82.9%)

1580 (81.4%)

 

 Positive

260 (19.2%)

100 (17.1%)

360 (18.6%)

 

 HPV-16/18/45

59 (4.4%)

24 (4.1%)

83 (4.3%)

 

 Other HPV

215(15.9%)

86 (14.7%)

301 (15.5%)

 

Histology (% of HPV positive women)

   

0.437

 Normal

179 (68.8%)

62 (62%)

241 (66.9%)

 

 CIN1

44 (16.9%)

18 (18%)

62 (17.2%)

 

 CIN2+

28 (10.8%)

11 (11%)

39 (10.8%)

 
  1. Abbreviations: CHW Community Health Workers, CIC Community Information Channels, SD Standard Deviation, IQR Interquartile range, HIV Human immunodeficiency virus, HPV Human papillomavirus, n number
  2. *p-values were estimated using chi-squared test, t-test as appropriate